Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting enzymes involved in inflammatory diseases and cancer. Its structure allows for selective binding to ATP sites in kinases, making it valuable in developing targeted therapies. Also explored in the design of CNS-active compounds due to its ability to cross the blood-brain barrier. The oxalate salt form enhances stability and crystallinity, beneficial for purification and formulation in drug development.